(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

REGIMES DE DOSAGEM DE ANTICORPOS CONTRA B7-H4

ArquivadaInvention PatentPCT · US2019018963

Application data

Number

112020016990

Type

Invention Patent

Filing

02/21/2019

Publication

02/23/2021

PCT

US2019018963

Progress at the INPI

  1. Filing02/21/19
  2. Publication02/23/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 02/21/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 08/16/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

FIVE PRIME THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

H. C. (pessoa física)

US

H. X. (pessoa física)

US

S. I. (pessoa física)

US

X. Z. (pessoa física)

US

Technical data

Priority claims

US

62/633,527 · 02/21/2018

US

62/802,100 · 02/06/2019

Abstract

A presente divulgação fornece métodos de administração de anticorpos e fragmentos de ligação ao antígeno deste que se ligam especificamente à B7-H4 humana a um sujeito em necessidade, por exemplo, um paciente com câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

08/16/2022

RPI 2693

Arquivamento - Art. 33 da LPI

#11.1

05/31/2022

RPI 2682

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

02/23/2021

RPI 2616

Exigências diversas

#1.5

Apresente o relatório descritivo.

12/15/2020

RPI 2606

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.